Neonc Technologies Holdings (NTHI) Restructuring Costs (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Restructuring Costs of $251968.0 for Q1 2026, up 75.36% year-over-year from $143684.0 in Q1 2025, and down 85.4% quarter-over-quarter from $1.7 million in Q4 2025.
Neonc Technologies Holdings (NTHI) Restructuring Costs (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Restructuring Costs for 3 consecutive years, with $251968.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Restructuring Costs rose 75.36% year-over-year to $251968.0; the TTM figure through Mar 2026 stood at $3.1 million (up 329.16% YoY), while the FY2025 annual figure was $3.0 million, up 254.66% from the prior year.
- Restructuring Costs eased to $251968.0 in Q1 2026 per NTHI's latest filing, from $1.7 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $1.7 million in Q4 2025 and bottomed at $120425.0 in Q4 2024.
- Historically, Restructuring Costs has averaged $478436.2 across 3 years, with a median of $252658.0 in 2024.
- Annual changes were most pronounced in 2025 — Restructuring Costs surged 1333.45% — and 2026, when it soared 75.36%.
- Neonc Technologies Holdings' Restructuring Costs stood at $120425.0 in 2024, then soared by 1333.45% to $1.7 million in 2025, then sank by 85.4% to $251968.0 in 2026.
- Business Quant data shows NTHI's Restructuring Costs at $251968.0 in Q1 2026, $1.7 million in Q4 2025, and $532359.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 569,952.00 |
| Mar 31, 2026 | 251,968.00 |
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 532,359.00 |
| Jun 30, 2025 | 593,609.00 |
| Mar 31, 2025 | 143,684.00 |
| Dec 31, 2024 | 120,425.00 |
| Sep 30, 2024 | 253,348.00 |
| Jun 30, 2024 | 205,860.00 |